Nkarta gets FDA approval for outpatient dosing of autoimmune therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Nkarta gets FDA approval for outpatient dosing of autoimmune therapy
(NASDAQ: NKTX) Delayed: 2.86 +0.10 (3.62%)
Previous Close $2.76    52 Week High $ 
Open $2.76    52 Week Low $ 
Day High $2.95    P/E N/A 
Day Low $2.71    EPS $ 
Volume 677,588